Omodenbamab immunoglobulin, designated with the code 2241724-48-9, constitutes a novel monoclonal protein currently subject to investigation regarding its expected therapeutic applications: uses, specifically targeting adcy2. Researchers: Scientists intend to exploring its way of operation and evaluating: assessing its ability in: regarding differe